Ipharma Ltd

POWER SEARCH PRICING

SOLUTIONS

ipharma ltd Company Information

Live

EstablishedSmallDeclining

Company Number

07171163

Website

www.i-pharma.co.uk

Registered Address

unit 4 hockley industrial estate, pitsford street, birmingham, B18 6PT

Industry

Other human health activities

Telephone

01213260010

Next Accounts Due

November 2024

Group Structure

View All

Directors

Mohammad Uddin14 Years

Shareholders

khalid hussain 66.5%

mohammad zaki uddin 17%

View All

ipharma ltd Estimated Valuation

£37.4k - £641.9k

The estimated valuation range for ipharma ltd, derived from financial data as of February 2023 and the most recent industry multiples, is between £37.4k to £641.9k

Get a detailed valuation report, edit figures and unlock valuation multiples.

Ipharma Ltd AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Ipharma Ltd is a live company located in birmingham, B18 6PT with a Companies House number of 07171163. It operates in the other human health activities sector, SIC Code 86900. Founded in February 2010, it's largest shareholder is khalid hussain with a 66.5% stake. Ipharma Ltd is a established, small sized company, Pomanda has estimated its turnover at £1.4m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Ipharma Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 7 areas for improvement. Company Health Check FAQs

Health Rating3out of 5

3 Strong

2 Regular

7 Weak

Size

annual sales of £1.4m, make it larger than the average company (£658.3k)

Growth

3 year (CAGR) sales growth of -2%, show it is growing at a slower rate (5.2%)

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for ipharma ltd. Get real-time insights into ipharma ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for ipharma ltd by selecting its closest rivals and benchmarking them against 12 key performance metrics.

IPHARMA LTD group structure

Ipharma Ltd has no subsidiary companies.

Ultimate parent company

IPHARMA LTD

07171163

IPHARMA LTD Shareholders

khalid hussain	66.5%
mohammad zaki uddin	17%
jawad t. mirza	16.5%

Ipharma Ltd currently has 1 director, Mr Mohammad Uddin serving since Feb 2010.

officer	country	age	start	end	role
Mr Mohammad Uddin		42 years	Feb 2010	-	Director

EXPORT

Ipharma Ltd's latest turnover from February 2023 is estimated at £1.4 million and the company has net assets of £42.7 thousand. According to their latest financial statements, Ipharma Ltd has 10 employees and maintains cash reserves of £58.1 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Feb 2023	Feb 2022	Feb 2021	Feb 2020	Feb 2019	Feb 2018	Feb 2017	Feb 2016	Feb 2015	Feb 2014	Feb 2013	Feb 2012	Feb 2011
Turnover	1,350,114	1,964,795	1,818,749	1,444,762	1,942,946	1,588,168	1,574,426	2,235,181	6,102,507	6,114,668	4,113,135	3,337,392	1,461,336
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	848,529	1,267,368	1,211,040	941,408	1,275,000	1,003,433	976,221	1,389,089	3,808,402	3,833,853	2,482,891	1,908,896	824,193
Gross Profit	501,585	697,426	607,709	503,354	667,946	584,735	598,205	846,092	2,294,105	2,280,816	1,630,244	1,428,495	637,142
Admin Expenses	496,221	718,636	538,810	514,542	679,624	571,255	595,870	895,546	2,284,383	2,038,848	1,421,335	1,576,398	780,151
Operating Profit	5,364	-21,210	68,899	-11,188	-11,678	13,480	2,335	-49,454	9,722	241,968	208,909	-147,903	-143,009
Interest Payable	0	1,625	1,525	0	0	0	40	41	0	0	0	0	0
Interest Receivable	1,867	385	114	654	389	136	45	234	565	380	8	66	59
Pre-Tax Profit	7,231	-22,450	67,488	-10,534	-11,289	13,616	2,340	-49,261	10,286	242,348	208,917	-147,837	-142,950
Tax	-1,374	0	-12,823	0	0	-2,587	-468	0	-2,160	-55,740	-50,140	0	0
Profit After Tax	5,857	-22,450	54,665	-10,534	-11,289	11,029	1,872	-49,261	8,126	186,608	158,777	-147,837	-142,950
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	5,857	-22,450	54,665	-10,534	-11,289	11,029	1,872	-49,261	8,126	186,608	158,777	-147,837	-142,950
Employee Costs	242,780	162,056	136,199	111,448	151,976	126,856	125,195	169,078	3,396,952	3,424,025	2,287,175	1,849,763	801,312
Number Of Employees	10	7	6	5	7	6	6	8	156	161	107	87	39
EBITDA*	8,778	-17,631	72,014	-7,497	-8,522	17,328	6,708	-44,609	13,330	248,650	217,817	-147,062	-141,887

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Feb 2023	Feb 2022	Feb 2021	Feb 2020	Feb 2019	Feb 2018	Feb 2017	Feb 2016	Feb 2015	Feb 2014	Feb 2013	Feb 2012	Feb 2011
Tangible Assets	15,552	16,303	19,882	22,997	14,375	17,531	21,379	22,070	16,435	20,043	26,725	2,524	3,365
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	15,552	16,303	19,882	22,997	14,375	17,531	21,379	22,070	16,435	20,043	26,725	2,524	3,365
Stock & work in progress	31,251	45,125	44,375	59,375	81,650	83,856	78,856	72,457	93,522	101,431	79,587	61,500	50,000
Trade Debtors	141,917	210,182	193,484	93,136	177,738	150,620	172,303	249,902	364,974	304,245	187,316	126,988	51,356
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	51,150	39,119	46,343	42,778	40,516	39,758	36,772	36,756	0	0	0	0	0
Cash	58,053	35,303	118,769	108,831	65,529	38,264	16,279	19,581	74,215	151,603	516	2,624	23,721
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	282,371	329,729	402,971	304,120	365,433	312,498	304,210	378,696	532,711	557,279	267,419	191,112	125,077
total assets	297,923	346,032	422,853	327,117	379,808	330,029	325,589	400,766	549,146	577,322	294,144	193,636	128,442
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	194,399	266,375	225,321	310,939	355,855	298,182	278,875	361,253	486,322	522,624	426,054	484,323	271,292
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	1,273	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	60,811	42,801	88,226	11,537	8,778	5,383	31,279	24,677	0	0	0	0	0
total current liabilities	255,210	309,176	313,547	322,476	364,633	303,565	310,154	387,203	486,322	522,624	426,054	484,323	271,292
loans	0	0	50,000	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	50,000	0	0	0	0	0	0	0	0	0	0
total liabilities	255,210	309,176	363,547	322,476	364,633	303,565	310,154	387,203	486,322	522,624	426,054	484,323	271,292
net assets	42,713	36,856	59,306	4,641	15,175	26,464	15,435	13,563	62,824	54,698	-131,910	-290,687	-142,850
total shareholders funds	42,713	36,856	59,306	4,641	15,175	26,464	15,435	13,563	62,824	54,698	-131,910	-290,687	-142,850

	Feb 2023	Feb 2022	Feb 2021	Feb 2020	Feb 2019	Feb 2018	Feb 2017	Feb 2016	Feb 2015	Feb 2014	Feb 2013	Feb 2012	Feb 2011
Operating Activities
Operating Profit	5,364	-21,210	68,899	-11,188	-11,678	13,480	2,335	-49,454	9,722	241,968	208,909	-147,903	-143,009
Depreciation	3,414	3,579	3,115	3,691	3,156	3,848	4,373	4,845	3,608	6,682	8,908	841	1,122
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	-1,374	0	-12,823	0	0	-2,587	-468	0	-2,160	-55,740	-50,140	0	0
Stock	-13,874	750	-15,000	-22,275	-2,206	5,000	6,399	-21,065	-7,909	21,844	18,087	11,500	50,000
Debtors	-56,234	9,474	103,913	-82,340	27,876	-18,697	-77,583	-78,316	60,729	116,929	60,328	75,632	51,356
Creditors	-71,976	41,054	-85,618	-44,916	57,673	19,307	-82,378	-125,069	-36,302	96,570	-58,269	213,031	271,292
Accruals and Deferred Income	18,010	-45,425	76,689	2,759	3,395	-25,896	6,602	24,677	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	23,546	-32,226	-38,651	54,961	26,876	21,849	1,648	-45,620	-77,952	150,707	30,993	-21,163	28,049
Investing Activities
capital expenditure	-2,663	0	0	-12,313	0	0	-3,682	-10,480	0	0	-33,109	0	-4,487
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-2,663	0	0	-12,313	0	0	-3,682	-10,480	0	0	-33,109	0	-4,487
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	-1,273	1,273	0	0	0	0	0
Long term loans	0	-50,000	50,000	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	0	0	0	0	0	0	0	0	0	0	100
interest	1,867	-1,240	-1,411	654	389	136	5	193	565	380	8	66	59
cash flow from financing	1,867	-51,240	48,589	654	389	136	-1,268	1,466	565	380	8	66	159
cash and cash equivalents
cash	22,750	-83,466	9,938	43,302	27,265	21,985	-3,302	-54,634	-77,388	151,087	-2,108	-21,097	23,721
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	22,750	-83,466	9,938	43,302	27,265	21,985	-3,302	-54,634	-77,388	151,087	-2,108	-21,097	23,721

P&L

February 2023

turnover

1.4m

-31%

operating profit

5.4k

gross margin

37.2%

+4.66%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

February 2023

net assets

42.7k

+0.16%

total assets

297.9k

-0.14%

cash

58.1k

+0.64%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

walsall road partnership limited

able 2 occupational therapy services limited

1.5

a3s eyes limited

3.5

prokare limited

4.5

a c optics limited

2.5

company number

07171163

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

February 2010

age

accounts

Total Exemption Full

ultimate parent company

None

previous names

N/A

incorporated

address

unit 4 hockley industrial estate, pitsford street, birmingham, B18 6PT

last accounts submitted

February 2023

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to ipharma ltd.

ipharma ltd Company Information

ipharma ltd Estimated Valuation

ipharma ltd Estimated Valuation

ipharma ltd Estimated Valuation

Ipharma Ltd AI Business Plan

Ipharma Ltd Overview

Ipharma Ltd Health Check

ipharma ltd Credit Report and Business Information

Ipharma Ltd Competitor Analysis

ipharma ltd Ownership

ipharma ltd directors

IPHARMA LTD financials

ipharma ltd company details

ipharma ltd Charges & Mortgages

ipharma ltd Companies House Filings - See Documents